Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Journal article

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet (London, England), 400, 832 - 845

Hospital costs associated with adverse events in people with diabetes in the UK

Journal article

Keng MJ. et al, (2022), Diabetes, Obesity and Metabolism

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

Decrements in health-related quality of life associated with adverse events in people with diabetes.

Journal article

Keng MJ. et al, (2022), Diabetes Obes Metab, 24, 530 - 538

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.

Journal article

Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342

Randomization versus Real-World Evidence. Reply.

Journal article

Collins R. et al, (2020), N Engl J Med, 383

The Magic of Randomization versus the Myth of Real-World Evidence.

Journal article

Collins R. et al, (2020), N Engl J Med, 382, 674 - 678

Load More